NCT04073953View on ClinicalTrials.gov

Primaquine Enantiomers in G6PD Deficient Human Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 1, 2020

Primary Completion Date

September 1, 2023

Study Completion Date

September 1, 2023

Conditions
G6PD Deficiency
Interventions
DRUG

RPQ

The study will compare the individual enantiomers of Primaquine -R-(-)-PQ, S-(+)-PQ, and Placebo.

DRUG

SPQ

The study will compare the individual enantiomers of Primaquine -R-(-)-PQ, S-(+)-PQ, and Placebo.

DRUG

Placebo

The study will compare the individual enantiomers of Primaquine -R-(-)-PQ, S-(+)-PQ, and Placebo.

Trial Locations (1)

38677

University of Mississippi, University

All Listed Sponsors
collaborator

University of Colorado, Denver

OTHER

lead

University of Mississippi, Oxford

OTHER

NCT04073953 - Primaquine Enantiomers in G6PD Deficient Human Volunteers | Biotech Hunter | Biotech Hunter